E-mail: info@tlph.com.la
Niraparib (Niraparib)
Nirapali is a PARP inhibitor. PARP inhibitors are targeted therapies that kill cancer cells by inhibiting PARP-mediated DNA damage repair response (DDR). Using the principle of "synthetic lethality", they can kill cancer cells while leaving healthy cells unaffected.
Address: Rd.13 South, 31 km Ban Naphasuk,
SaithanyDistrict, Vientiane, Lao PDR 
E-mail: info@tlph.com.la 
WeChat: TLPH01 
Website: https: //tlph.com.la